TrialPharmacological reports : PR2026

Topical latanoprost acid for female androgenetic alopecia: a pilot proof-of-concept trial with mechanistic evidence of prostaglandin F2α receptor activation.

Adriana Rakowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.